Eluforsen Found to be Safe for Adults with Cystic Fibrosis Caused by F508del Mutation, Study Reports
The experimental treatment eluforsen is safe for adults with cystic fibrosis(CF) caused by a mutation called F508del, a new study...
Slammed by Side Effects: The Downside of Antibiotics
Everyone with cystic fibrosis knows that feeling. Sometimes, it creeps up on you slowly. Other times, it hits right away, like a truck...
Trial of Nebulized CF Candidate Therapy Completes Single-ascending Dosing
The RESTORE-CF clinical trial investigating Translate Bio’s candidate therapy MRT5005 has completed the single-ascending dose regimen in...
Specific Peptide May Lower Antibiotic Resistance of P. aeruginosa Bacteria, Study Reports
Expression of a peptide called RpoN* in antibiotic-resistant Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients made the...
Incidence of CF-related Diabetes Stable in Pediatric CF, Canadian Study Finds
The incidence rate of cystic fibrosis-related diabetes (CFRD) in children with cystic fibrosis (CF) has remained stable over time,...
Poor Oxygen Conditions May Promote P. aeruginosa Infection Over Other Pathogen in CF, Study Suggests
Poor oxygen conditions, a common trait in the lungs of cystic fibrosis (CF) patients, may help Pseudomonas aeruginosa bacteria outcompete...
Incidence of Non-CF Bronchiectasis is Rising in Germany, Study Reports
The incidence of non-cystic fibrosis bronchiectasis is rising in Germany, which necessitates a better understanding of the economic...
Decreasing Acidity of Airway Liquid in Newborn CF Patients May Reduce Infection Risk, Study Suggests
Normalizing the acidity in the thin layer of liquid covering the airways of newborns with cystic fibrosis might make them more resistant...
Diabetes and Insulin Treatment Adds to CF Burden and Ways Are Needed to Ease It, Study Says
Having to take insulin to treat cystic fibrosis-related diabetes (CFRD) adds to patient distress and sense of a poorer quality of life, a...
Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 fo
NEW YORK and CLEVELAND, April 30, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and...
